866-997-4948(US-Canada Toll Free)

Asia-Pacific Retinal Drugs and Biologics Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

In this report, the Asia-Pacific Retinal Drugs and Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Retinal Drugs and Biologics for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Retinal Drugs and Biologics market competition by top manufacturers/players, with Retinal Drugs and Biologics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Alimera Sciences
Janssen Biotech
F. Hoffmann-La Roche Ltd
Genzyme Corporation
Ocular Therapeutix
UCBCares
Allergan
AbbVie Inc
Swedish Orphan Biovitrum
Bristol-Myers Squibb Company
Genentech USA
Bausch & Lomb Incorporated

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Surgery
Medicines
Retinal Laser
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Retinal Drugs and Biologics for each application, includin
Hospital Pharmacies
Retail Pharmacies
Specialty Ophthalmology Clinics
Others
Table of Contents

Asia-Pacific Retinal Drugs and Biologics Market Report 2017
1 Retinal Drugs and Biologics Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Classification of Retinal Drugs and Biologics by Product Category
1.2.1 Asia-Pacific Retinal Drugs and Biologics Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Retinal Drugs and Biologics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Surgery
1.2.4 Medicines
1.2.5 Retinal Laser
1.2.6 Others
1.3 Asia-Pacific Retinal Drugs and Biologics Market by Application/End Users
1.3.1 Asia-Pacific Retinal Drugs and Biologics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Ophthalmology Clinics
1.3.5 Others
1.4 Asia-Pacific Retinal Drugs and Biologics Market by Region
1.4.1 Asia-Pacific Retinal Drugs and Biologics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Retinal Drugs and Biologics (2012-2022)
1.5.1 Asia-Pacific Retinal Drugs and Biologics Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Retinal Drugs and Biologics Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Retinal Drugs and Biologics Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Retinal Drugs and Biologics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Retinal Drugs and Biologics (Volume and Value) by Type
2.2.1 Asia-Pacific Retinal Drugs and Biologics Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Retinal Drugs and Biologics (Volume) by Application
2.4 Asia-Pacific Retinal Drugs and Biologics (Volume and Value) by Region
2.4.1 Asia-Pacific Retinal Drugs and Biologics Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Market Share by Region (2012-2017)

3 China Retinal Drugs and Biologics (Volume, Value and Sales Price)
3.1 China Retinal Drugs and Biologics Sales and Value (2012-2017)
3.1.1 China Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
3.1.2 China Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
3.1.3 China Retinal Drugs and Biologics Sales Price Trend (2012-2017)
3.2 China Retinal Drugs and Biologics Sales Volume and Market Share by Type
3.3 China Retinal Drugs and Biologics Sales Volume and Market Share by Application

4 Japan Retinal Drugs and Biologics (Volume, Value and Sales Price)
4.1 Japan Retinal Drugs and Biologics Sales and Value (2012-2017)
4.1.1 Japan Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
4.1.3 Japan Retinal Drugs and Biologics Sales Price Trend (2012-2017)
4.2 Japan Retinal Drugs and Biologics Sales Volume and Market Share by Type
4.3 Japan Retinal Drugs and Biologics Sales Volume and Market Share by Application

5 South Korea Retinal Drugs and Biologics (Volume, Value and Sales Price)
5.1 South Korea Retinal Drugs and Biologics Sales and Value (2012-2017)
5.1.1 South Korea Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Retinal Drugs and Biologics Sales Price Trend (2012-2017)
5.2 South Korea Retinal Drugs and Biologics Sales Volume and Market Share by Type
5.3 South Korea Retinal Drugs and Biologics Sales Volume and Market Share by Application

6 Taiwan Retinal Drugs and Biologics (Volume, Value and Sales Price)
6.1 Taiwan Retinal Drugs and Biologics Sales and Value (2012-2017)
6.1.1 Taiwan Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Retinal Drugs and Biologics Sales Price Trend (2012-2017)
6.2 Taiwan Retinal Drugs and Biologics Sales Volume and Market Share by Type
6.3 Taiwan Retinal Drugs and Biologics Sales Volume and Market Share by Application

7 India Retinal Drugs and Biologics (Volume, Value and Sales Price)
7.1 India Retinal Drugs and Biologics Sales and Value (2012-2017)
7.1.1 India Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
7.1.2 India Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
7.1.3 India Retinal Drugs and Biologics Sales Price Trend (2012-2017)
7.2 India Retinal Drugs and Biologics Sales Volume and Market Share by Type
7.3 India Retinal Drugs and Biologics Sales Volume and Market Share by Application

8 Southeast Asia Retinal Drugs and Biologics (Volume, Value and Sales Price)
8.1 Southeast Asia Retinal Drugs and Biologics Sales and Value (2012-2017)
8.1.1 Southeast Asia Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Retinal Drugs and Biologics Sales Price Trend (2012-2017)
8.2 Southeast Asia Retinal Drugs and Biologics Sales Volume and Market Share by Type
8.3 Southeast Asia Retinal Drugs and Biologics Sales Volume and Market Share by Application

9 Australia Retinal Drugs and Biologics (Volume, Value and Sales Price)
9.1 Australia Retinal Drugs and Biologics Sales and Value (2012-2017)
9.1.1 Australia Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
9.1.3 Australia Retinal Drugs and Biologics Sales Price Trend (2012-2017)
9.2 Australia Retinal Drugs and Biologics Sales Volume and Market Share by Type
9.3 Australia Retinal Drugs and Biologics Sales Volume and Market Share by Application

10 Asia-Pacific Retinal Drugs and Biologics Players/Suppliers Profiles and Sales Data
10.1 Alimera Sciences
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Janssen Biotech
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 F. Hoffmann-La Roche Ltd
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Genzyme Corporation
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Genzyme Corporation Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Ocular Therapeutix
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Ocular Therapeutix Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 UCBCares
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 UCBCares Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Allergan
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Allergan Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 AbbVie Inc
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 AbbVie Inc Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Swedish Orphan Biovitrum
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Bristol-Myers Squibb Company
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Genentech USA
10.12 Bausch & Lomb Incorporated

11 Retinal Drugs and Biologics Manufacturing Cost Analysis
11.1 Retinal Drugs and Biologics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Retinal Drugs and Biologics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Retinal Drugs and Biologics Market Forecast (2017-2022)
15.1 Asia-Pacific Retinal Drugs and Biologics Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Retinal Drugs and Biologics Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Retinal Drugs and Biologics Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Retinal Drugs and Biologics Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Retinal Drugs and Biologics Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Retinal Drugs and Biologics Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Retinal Drugs and Biologics Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Retinal Drugs and Biologics Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Retinal Drugs and Biologics Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Retinal Drugs and Biologics Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Retinal Drugs and Biologics
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume Market Share by Type (Product Category) in 2016
Figure Surgery Product Picture
Figure Medicines Product Picture
Figure Retinal Laser Product Picture
Figure Others Product Picture
Figure Asia-Pacific Retinal Drugs and Biologics Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Retinal Drugs and Biologics by Application in 2016
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Specialty Ophthalmology Clinics Examples
Figure Others Examples
Figure Asia-Pacific Retinal Drugs and Biologics Market Size (Million USD) by Region (2012-2022)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure Asia-Pacific Retinal Drugs and Biologics Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Retinal Drugs and Biologics Revenue Share by Players
Figure 2017 Asia-Pacific Retinal Drugs and Biologics Revenue Share by Players
Table Asia-Pacific Retinal Drugs and Biologics Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales Share by Type (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Type (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales Share by Region (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Market Share by Region in 2016
Table Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue Market Share by Region in 2016
Table Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Retinal Drugs and Biologics Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Market Share by Application (2012-2017)
Figure China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table China Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Japan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Japan Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure South Korea Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table South Korea Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure South Korea Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table South Korea Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure South Korea Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Taiwan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Taiwan Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure India Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure India Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table India Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure India Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Southeast Asia Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Australia Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Australia Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Australia Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Australia Retinal Drugs and Biologics Sales Volume (K Units) by Applications (2012-2017)
Table Australia Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Australia Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Table Alimera Sciences Retinal Drugs and Biologics Basic Information List
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Janssen Biotech Retinal Drugs and Biologics Basic Information List
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Basic Information List
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Genzyme Corporation Retinal Drugs and Biologics Basic Information List
Table Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Ocular Therapeutix Retinal Drugs and Biologics Basic Information List
Table Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table UCBCares Retinal Drugs and Biologics Basic Information List
Table UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Allergan Retinal Drugs and Biologics Basic Information List
Table Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Allergan Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table AbbVie Inc Retinal Drugs and Biologics Basic Information List
Table AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Basic Information List
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Basic Information List
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Revenue Market Share in Asia-Pacific (2012-2017)
Table Genentech USA Retinal Drugs and Biologics Basic Information List
Table Bausch & Lomb Incorporated Retinal Drugs and Biologics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2016
Table Major Buyers of Retinal Drugs and Biologics
Table Distributors/Traders List
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue Market Share Forecast by Region in 2022
Figure China Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Retinal Drugs and Biologics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Retinal Drugs and Biologics Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Retinal Drugs and Biologics Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Retinal Drugs and Biologics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *